UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000056560
Receipt number R000064637
Scientific Title Efficacy test of study to examine the adsorption and penetration of zinc into keratin plugs by continuous use of zinc oxide preparations
Date of disclosure of the study information 2025/01/06
Last modified on 2026/01/16 16:29:13

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy test of study to examine the adsorption and penetration of zinc into keratin plugs by continuous use of zinc oxide preparations

Acronym

Efficacy test of study to examine the adsorption and penetration of zinc into keratin plugs by continuous use of zinc oxide preparations

Scientific Title

Efficacy test of study to examine the adsorption and penetration of zinc into keratin plugs by continuous use of zinc oxide preparations

Scientific Title:Acronym

Efficacy test of study to examine the adsorption and penetration of zinc into keratin plugs by continuous use of zinc oxide preparations

Region

Japan


Condition

Condition

Not applicable

Classification by specialty

Not applicable Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To preliminarily verify whether zinc oxide preparations can be used continuously to adsorb and penetrate keratin plugs.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Evaluation of the amount of zinc adsorbed onto the surface of keratin plugs and the degree of zinc penetration into the keratin plugs after one week of continuous use of the preparation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Apply product with ZnO to the face twice a day for 1wks.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male and Female

Key inclusion criteria

1. Men and women aged 20-59
2. Regular employees working at Kao Corporation's Sumida Plant
3. Those who do not normally use UV preparations or makeup products that contain UV scattering agents
(If you use above products, you must not use them for at least one week before participating in the study.)

Key exclusion criteria

1.Those who are pregnant or may be pregnant, breastfeeding, or less than 6 months postpartum
2.Those who have participated in other studies (all studies using cosmetics, food, pharmaceuticals, quasi-drugs, medical devices, etc.) within the past 4 weeks, or those who have participated in other human studies during the scheduled implementation period of this study. Those who are planning to participate.
3.Those with skin symptoms such as atopic dermatitis or contact dermatitis.
4.Those with a history of allergies or rashes to cosmetics, adhesive tapes, medical tapes, etc.
5.Those with facial skin abnormalities (rash, eczema, wounds, bruises, etc.).
6.Those who have had severe sunburn on their face within the past month
7.Those who are visiting a medical institution due to poor physical condition or skin disease.
8.Those using cosmetics, quasi-drugs, or pharmaceuticals that may affect the test (peels, steroids, anti-inflammatory drugs, topical drugs, antibacterial drugs, etc.).
9.Those with seasonal allergies such as severe hay fever.
10.Those who have received cosmetic treatment for the face (laser treatment, collagen injection, etc.).
11.Those who have had aesthetic treatment on their face within the past month
12.Those who use home facial beauty devices or beauty equipment
13.Those who have a habit of smoking.
14.Those who are deemed unsuitable for research participation by the research director due to violation of compliance obligations, etc.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name Kaori
Middle name
Last name Tojo

Organization

Kao Corporation

Division name

Skin Care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7286

Email

tojo.kaori@kao.com


Public contact

Name of contact person

1st name Masafumi
Middle name
Last name Takata

Organization

Kao Corporation

Division name

Skin Care Research Lab.

Zip code

131-8501

Address

2-1-3, Bunka, Sumida-ku, Tokyo, 131-8501, JAPAN

TEL

+81-3-5630-7286

Homepage URL


Email

takata.masafumi@kao.com


Sponsor or person

Institute

Kao Corporation

Institute

Department

Personal name



Funding Source

Organization

Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Human Research Ethics Committee, Kao Corporation

Address

2-1-3 Bunka, Sumida-ku, Tokyo 131-8501, JAPAN

Tel

+81-3-5630-9064

Email

morisaki.naoko@kao.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications

None

Number of participants that the trial has enrolled

20

Results

Repeated use of the product may cause zinc to adsorb to and penetrate keratin plug

Results date posted

2026 Year 01 Month 16 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Men and women aged 30 to 59

Participant flow

N = 20 at baseline; no loss to follow-up.

Adverse events

None

Outcome measures

Zinc adsorption and penetration in keratin plug

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2024 Year 12 Month 12 Day

Date of IRB

2024 Year 12 Month 12 Day

Anticipated trial start date

2025 Year 01 Month 06 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 12 Month 25 Day

Last modified on

2026 Year 01 Month 16 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064637